This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
What are the CE indications for BrainsWay Deep TMS?
BrainsWay’s Deep TMS therapy has been cleared by Europe’s CE certification for treating a variety of disorders:
Alzheimer’s disease
Autism
Bipolar Disorder
Chronic Pain
Major Depressive Disorder (MDD)
Parkinson’s disease
Post-traumatic Stress Disorder (PTSD)
Schizophrenia (negative symptoms)
Smoking cessation
Stroke
Multiple Sclerosis
Obsessive Compulsive Disorder (OCD)
BrainsWay has also been cleared by the FDA for treatment resistant Major Depressive Disorder (MDD) and Obsessive Compulsive Disorder (OCD).
You may also be interested in...
What mental health conditions is Deep TMS FDA-cleared to treat?
BrainsWay's Deep TMS is currently FDA-cleared to treat both Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD). With promising new studies in the pipeline, additional mental healt...
Who is authorized to administer Deep TMS treatment?
The ability to prescribe and administer Deep TMS therapy varies according to local laws and insurance policies. Psychiatrists are universally able to offer dTMS care, with other mental healthcare prof...
Does Deep TMS require any special equipment or facilities?
Deep TMS treatment requires certain amenities to ensure patients receive a comfortable, professional process before, during and after the treatment itself. This includes features such as a treatment s...